Pages that link to "Q24567623"
Jump to navigation
Jump to search
The following pages link to Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain (Q24567623):
Displayed 50 items.
- Transcriptional activators of human genes with programmable DNA-specificity (Q21091041) (← links)
- Less is more: strategies to remove marker genes from transgenic plants (Q21256671) (← links)
- Site specific mutation of the Zic2 locus by microinjection of TALEN mRNA in mouse CD1, C3H and C57BL/6J oocytes (Q21559671) (← links)
- Generation of knockout rabbits using transcription activator-like effector nucleases (Q22001128) (← links)
- DNA-catalyzed sequence-specific hydrolysis of DNA (Q22122102) (← links)
- Genome-scale engineering for systems and synthetic biology (Q22122302) (← links)
- Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells (Q24535831) (← links)
- Cas9 as a versatile tool for engineering biology (Q24564294) (← links)
- RNA-guided human genome engineering via Cas9 (Q24598394) (← links)
- Targeting DNA With Fingers and TALENs (Q24599859) (← links)
- TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain (Q24603277) (← links)
- Precision editing of large animal genomes (Q24611750) (← links)
- Zinc-finger nuclease-induced gene repair with oligodeoxynucleotides: wanted and unwanted target locus modifications (Q24630071) (← links)
- Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificities (Q24644274) (← links)
- Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases (Q24647647) (← links)
- Expression and purification of BmrI restriction endonuclease and its N-terminal cleavage domain variants (Q24649467) (← links)
- Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases (Q24652815) (← links)
- Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly (Q24655166) (← links)
- FokI dimerization is required for DNA cleavage (Q24657843) (← links)
- Structure of FokI has implications for DNA cleavage (Q24657897) (← links)
- Generation of DNA cleavage specificities of type II restriction endonucleases by reassortment of target recognition domains (Q24669929) (← links)
- Zinc Finger Tools: custom DNA-binding domains for transcription factors and nucleases (Q24680179) (← links)
- Restriction endonuclease BpuJI specific for the 5'-CCCGT sequence is related to the archaeal Holliday junction resolvase family (Q24682734) (← links)
- Developing a programmed restriction endonuclease for highly specific DNA cleavage (Q24812943) (← links)
- Testing the causality between CYP9M10 and pyrethroid resistance using the TALEN and CRISPR/Cas9 technologies (Q26315518) (← links)
- Genome- and Cell-Based Strategies in Therapy of Muscular Dystrophies (Q26741955) (← links)
- Methods of Genome Engineering: a New Era of Molecular Biology (Q26741958) (← links)
- The emerging role of viral vectors as vehicles for DMD gene editing (Q26746647) (← links)
- In Vivo Delivery Systems for Therapeutic Genome Editing (Q26748886) (← links)
- Human induced pluripotent stem cells for monogenic disease modelling and therapy (Q26750393) (← links)
- Customizing the genome as therapy for the β-hemoglobinopathies (Q26751061) (← links)
- Genome Engineering with TALE and CRISPR Systems in Neuroscience (Q26752488) (← links)
- The Rise of CRISPR/Cas for Genome Editing in Stem Cells (Q26765852) (← links)
- The therapeutic potential of genome editing for β-thalassemia (Q26766232) (← links)
- Gene targeting, genome editing: from Dolly to editors (Q26768799) (← links)
- Genome-editing Technologies for Gene and Cell Therapy (Q26769662) (← links)
- Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off-target Effects in Genome Editing (Q26770012) (← links)
- Genome Editing and Its Applications in Model Organisms (Q26772108) (← links)
- Revolutionizing plant biology: multiple ways of genome engineering by CRISPR/Cas (Q26773013) (← links)
- Towards a new era in medicine: therapeutic genome editing (Q26773287) (← links)
- Targeting Non-Coding RNAs in Plants with the CRISPR-Cas Technology is a Challenge yet Worth Accepting (Q26774632) (← links)
- Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges (Q26775061) (← links)
- Applications of CRISPR-Cas systems in neuroscience (Q26776515) (← links)
- Origins of Programmable Nucleases for Genome Engineering (Q26778501) (← links)
- From Gene Targeting to Genome Editing: Transgenic animals applications and beyond (Q26781859) (← links)
- Enabling functional genomics with genome engineering (Q26782747) (← links)
- Strategies for precision modulation of gene expression by epigenome editing: an overview (Q26782876) (← links)
- Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools (Q26785684) (← links)
- Transgenic trait deployment using designed nucleases (Q26786503) (← links)
- Designed nucleases for targeted genome editing (Q26787105) (← links)